Announced Mon, 10 Aug · 13:43 IST
Artemis Q1 FY27: Strong Results, Margin Expansion Roadmap
Mgmt Guided Margin ImprovementPromoter Disclosed Acquisition PlansAnalyst Day Multiyear TargetsOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹317.65
prior close
₹319.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2+0.0-0.1+0.0-1.3+0.4-0.2-1.1-0.9-1.0————
Up moveDown movePending
AI summary
Q1 FY27 revenue up 12.7 percent YoY at INR 287 cr; EBITDA margin 21.5 percent, PAT up 48 percent to INR 31 cr. New 300-bed Raipur hospital operational from July. Gurugram Tower IV with 200 plus beds to be ready in 18 to 22 months. Management guides margins to 23 to 24 percent over 2 to 3 years. INR 700 cr QIP approved for brownfield acquisitions. Plans 2,000 beds by FY30.
Likely market impact
Clear margin improvement guidance plus INR 800 cr capex pipeline over 3 years supports sustained growth outlook.